3.00
price down icon5.10%   -0.14
after-market Handel nachbörslich: 3.06 0.06 +2.00%
loading

Finanzdaten der Nrx Pharmaceuticals Inc-Aktie (NRXP)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-03-31 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Income/Loss From Continuing Operations Before Tax
30.20%
-5.512
-7.897 -6.528 -4.332 -6.062
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
30.20%
-5.512
-7.897 -6.528 -4.332 -6.062
Net Income/Loss
30.20%
-5.512
-7.897 -6.528 -4.332 -6.062
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$36.41
price down icon 2.47%
$91.65
price down icon 1.56%
$29.13
price up icon 0.34%
$105.09
price down icon 0.85%
biotechnology ONC
$316.85
price up icon 0.47%
$165.29
price up icon 0.80%
Kapitalisierung:     |  Volumen (24h):